24Antibiotic resistant bacteria are a global threat to human health. One way to combat the 25 rise of antibiotic resistance is to make new antibiotics that target previously ignored 26 proteins. The bacterial actin homolog, MreB, is highly conserved among rod-shaped 27 bacteria and essential for growth, making MreB a good focus for antibiotic targeting. 28 Therefore, it is imperative to understand mechanisms that can give rise to resistance to 29 MreB targeting drugs. Using the MreB targeting drug, A22, we show that changes to 30 central metabolism through deletion of TCA cycle genes, leads to the upregulation of 31 gluconeogenesis resulting in cells with an increased minimal inhibitory concentration to 32 A22. This phenotype can be recapitulated through the addition of glucose to the media. 33Finally, we show that this increase in minimal inhibitory concentration is not specific to 34 A22 but can be seen in other cell wall targeting antibiotics, such as mecillinam. 35 36 Importance 37The spread of antibiotic resistance has made bacterial infections harder to treat. Finding 38 new targets for antibiotic development is critical to overcoming the variety of resistance 39 mechanism that are already crippling our ability to treat infections with current 40 antibiotics. The bacterial actin homolog MreB is a good target for new antibiotic 41 development because it is essential for growth and highly conserved among rod-shaped 42 pathogens. The significance of this research is in understanding the mechanisms cells 43 can develop toward the inhibition of MreB to better understand how to make MreB 44 targeting antibiotics in the future. 45Escherichia coli, Salmonella enterica, Pseudomonas aeruginosa, and Vibrio cholerae 63 (7, 8). Therefore, MreB is a good target candidate for new antibiotic development. While 64 there are no current FDA-approved MreB-targeting antibiotics, the compound A22 is 65 used in laboratory settings to study the role of MreB in the cell. A22 binds adjacent to 66 the ATP binding pocket of MreB and alters its polymerization dynamics (9-13). MreB 67 directs the localization of cell wall synthesis, and disruption of MreB, either through the 68 use of A22 or genetic modifications, causes cells to become misshapen and lyse. One 69